Jefferies Downgrades Option Care Health (OPCH) to Hold

Jefferies analyst Brian Tanquilut downgraded Option Care Health (NASDAQ: OPCH) from Buy to Hold with a price target of $26.00 (from $38.00).

The analyst said: "We downgrade OPCH to Hold from Buy and are reducing our PT to $26 from $38 given our belief that uncertainty with the pricing dynamics for the drug Stelara will persist over the next few months and keep OPCH shares range-bound. Given significant margin compression for Stelara, we cut our Stelara GP$ assumption in half to arrive at a ~5% reduction to '25 EBITDA. With lower visibility to underlying growth, we think valuation holds at ~11x EV/EBITDA over the NTM."

For an analyst ratings summary and ratings history on Option Care Health click here. For more ratings news on Option Care Health click here.

Shares of Option Care Health closed at $23.55 yesterday.

You May Also Be Interested In

• Apple suing OpenAI over alleged misappropriation of trade secrets
• Holtec Nuclear Corporation files for initial public offering
• iQSTEL restructures corporate entities in internal realignment